Acute kidney injury (AKI) is a sudden loss of kidney function that reduces waste removal and disrupts fluid, electrolyte, and acid-base balance. In Intro to Pharmacology, it matters because AKI changes how drugs are cleared and which medications may worsen kidney damage.
Acute kidney injury, or AKI, is a sudden drop in kidney function that happens over hours to days in Intro to Pharmacology. When the kidneys stop filtering well, creatinine rises, urine output may fall, and waste products can build up fast.
The basic idea is simple: the kidneys are not clearing blood the way they should. That changes fluid balance, electrolyte levels like potassium, and acid-base status. It also changes pharmacokinetics, because many drugs or their metabolites are removed through the kidneys.
AKI is usually grouped into three patterns. Prerenal AKI happens when blood flow to the kidneys drops, such as with dehydration or low blood pressure. Intrinsic AKI means the kidney tissue itself is injured, often from toxins, inflammation, or ischemia. Postrenal AKI happens when urine cannot drain because of an obstruction, such as a stone or enlarged prostate.
In pharmacology, the cause matters because the medication response changes with the type of injury. A patient with prerenal AKI may improve after fluids and stopping a harmful drug, while intrinsic damage may take longer to recover. If urine is blocked, fixing the obstruction is the first step, not just changing the prescription.
A common class to watch is NSAIDs, especially non-selective COX inhibitors. These drugs can reduce prostaglandin-mediated blood flow to the kidney, which can push a vulnerable patient into AKI. That is why a person who is already dehydrated, older, or taking other nephrotoxic drugs can get into trouble quickly.
For this course, AKI is less about memorizing a kidney disease list and more about seeing how organ function changes drug safety. If the kidneys cannot excrete a medication normally, the dose, interval, or even the choice of drug may need to change.
Acute kidney injury sits right at the intersection of renal physiology and medication safety. Once kidney function drops, the body may hold onto drugs longer, so a normal dose can become too strong or last too long. That is a big deal for medicines with narrow safety margins, but it also matters for common drugs that many patients take without thinking much about them.
This term also helps you connect side effects to mechanism. If a patient starts an NSAID and then develops rising creatinine or low urine output, you are not just naming a bad outcome, you are tracing how reduced prostaglandins can lower kidney perfusion. That kind of reasoning shows up in case questions, dosage adjustments, and medication review exercises.
AKI is also the point where pharmacology becomes practical. You have to think about hydration status, other comorbidities, and whether a drug should be held, reduced, or replaced. In real patient cases, the question is often not just “what drug is this?” but “what does the kidney do with it now?”
Keep studying Intro to Pharmacology Unit 6
Visual cheatsheet
view galleryNephrotoxicity
Nephrotoxicity is kidney damage caused by a drug or toxin, and it is one of the major ways intrinsic AKI can happen. When you see a medication that can injure renal tissue directly, think about rising creatinine, falling urine output, and the need to stop or switch the offending agent. AKI is the outcome, nephrotoxicity is often the cause.
Chronic Kidney Disease
Chronic kidney disease is long-term loss of kidney function, while AKI is sudden. The two can overlap, because someone with chronic kidney disease has less reserve and can tip into AKI more easily. In pharmacology, that means you often have to separate a temporary kidney hit from a baseline kidney problem before you decide on dosing.
Non-selective COX inhibitors
Non-selective COX inhibitors are a subtype of NSAIDs that block both COX-1 and COX-2. They can reduce prostaglandins that help preserve kidney blood flow, which is why they can trigger prerenal AKI in vulnerable patients. This connection is a classic example of how one drug mechanism can create a renal side effect.
glomerular filtration rate
Glomerular filtration rate, or GFR, is a measure of how well the kidneys are filtering blood. In AKI, GFR drops, so serum creatinine tends to rise and drug clearance slows down. Pharmacology questions often ask you to use a lowered GFR as the clue that a dose needs to be adjusted or avoided.
A quiz item or case study may give you a patient with low urine output, high creatinine, and recent NSAID use, then ask you to identify AKI and explain the likely type. You might also be asked what happens to a kidney-cleared drug when GFR falls, or which medication should be used more cautiously. The move is to connect symptoms, lab changes, and drug choice instead of treating AKI as a standalone diagnosis. If the case mentions dehydration, obstruction, or a nephrotoxic drug, use that clue to sort prerenal, intrinsic, or postrenal AKI. In discussion or short-answer work, you may need to explain why monitoring renal function matters before and after starting therapy.
These are easy to mix up because both affect kidney function and drug handling. AKI is sudden and may improve if the cause is fixed, while chronic kidney disease develops over time and is usually progressive. If the question mentions hours, days, or an acute trigger like dehydration or NSAID use, think AKI. If it mentions months, long-term decline, or persistent reduced GFR, think chronic kidney disease.
Acute kidney injury is a sudden drop in kidney function that can happen over hours or days.
AKI matters in pharmacology because it changes how the body clears drugs and can raise the risk of toxicity.
Prerenal, intrinsic, and postrenal are the three main patterns you use to sort the cause of AKI.
NSAIDs can contribute to AKI by lowering kidney blood flow through prostaglandin inhibition.
Rising creatinine and falling urine output are two of the biggest clues that kidney function has dropped.
Acute kidney injury is a sudden decline in kidney function that makes it harder for the body to filter waste, balance fluids, and clear drugs. In pharmacology, it matters because reduced kidney function can change dosing and increase the risk of medication toxicity.
No. AKI happens suddenly and can sometimes improve if the cause is treated, while chronic kidney disease builds up over time and usually reflects long-term kidney damage. A patient can have both, but they are not the same process.
NSAIDs can lower prostaglandin production, and prostaglandins help maintain blood flow to the kidneys. If kidney perfusion drops, especially in someone dehydrated or already at risk, AKI can develop. That is why NSAID use gets extra caution in renal impairment.
Rising serum creatinine and decreased urine output are classic clues. You may also see fluid imbalance or electrolyte changes, especially potassium problems. In a medication case, those findings make you think about renal dosing and whether a drug could be contributing.